pIRESneo-FLAG/HA EYFP Citations (9)
Originally described in: Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs.Meister G, Landthaler M, Patkaniowska A, Dorsett Y, Teng G, Tuschl T Mol Cell. 2004 Jul 23. 15(2):185-97. PubMed Journal
Articles Citing pIRESneo-FLAG/HA EYFP
| Articles |
|---|
| Argonaute proteins are key determinants of RNAi efficacy, toxicity, and persistence in the adult mouse liver. Grimm D, Wang L, Lee JS, Schurmann N, Gu S, Borner K, Storm TA, Kay MA. J Clin Invest. 2010 Sep;120(9):3106-19. doi: 10.1172/JCI43565. Epub 2010 Aug 9. PubMed |
| Expression determinants of mammalian argonaute proteins in mediating gene silencing. Valdmanis PN, Gu S, Schuermann N, Sethupathy P, Grimm D, Kay MA. Nucleic Acids Res. 2012 Apr;40(8):3704-13. doi: 10.1093/nar/gkr1274. Epub 2011 Dec 30. PubMed |
| Molecular dissection of human Argonaute proteins by DNA shuffling. Schurmann N, Trabuco LG, Bender C, Russell RB, Grimm D. Nat Struct Mol Biol. 2013 Jul;20(7):818-26. doi: 10.1038/nsmb.2607. Epub 2013 Jun 9. PubMed |
| Robust RNAi enhancement via human Argonaute-2 overexpression from plasmids, viral vectors and cell lines. Borner K, Niopek D, Cotugno G, Kaldenbach M, Pankert T, Willemsen J, Zhang X, Schurmann N, Mockenhaupt S, Serva A, Hiet MS, Wiedtke E, Castoldi M, Starkuviene V, Erfle H, Gilbert DF, Bartenschlager R, Boutros M, Binder M, Streetz K, Krausslich HG, Grimm D. Nucleic Acids Res. 2013 Nov;41(21):e199. doi: 10.1093/nar/gkt836. Epub 2013 Sep 17. PubMed |
| Regulation of microRNA-mediated gene silencing by microRNA precursors. Roy-Chaudhuri B, Valdmanis PN, Zhang Y, Wang Q, Luo QJ, Kay MA. Nat Struct Mol Biol. 2014 Sep;21(9):825-32. doi: 10.1038/nsmb.2862. Epub 2014 Aug 3. PubMed |
miR-34 activity is modulated through 5'-end phosphorylation in response to DNA damage.
Salzman DW, Nakamura K, Nallur S, Dookwah MT, Metheetrairut C, Slack FJ, Weidhaas JB.
Nat Commun. 2016 Mar 21;7:10954. doi: 10.1038/ncomms10954.
PubMed
Associated Plasmids |
| Tumor-Associated Macrophages Induce Endocrine Therapy Resistance in ER+ Breast Cancer Cells. Castellaro AM, Rodriguez-Baili MC, Di Tada CE, Gil GA. Cancers (Basel). 2019 Feb 6;11(2). pii: cancers11020189. doi: 10.3390/cancers11020189. PubMed |
| A pan-cancer analysis reveals nonstop extension mutations causing SMAD4 tumour suppressor degradation. Dhamija S, Yang CM, Seiler J, Myacheva K, Caudron-Herger M, Wieland A, Abdelkarim M, Sharma Y, Riester M, Gross M, Maurer J, Diederichs S. Nat Cell Biol. 2020 Aug;22(8):999-1010. doi: 10.1038/s41556-020-0551-7. Epub 2020 Jul 27. PubMed |
| RanBP2/Nup358 enhances miRNA activity by sumoylating Argonautes. Shen Q, Wang YE, Truong M, Mahadevan K, Wu JJ, Zhang H, Li J, Smith HW, Smibert CA, Palazzo AF. PLoS Genet. 2021 Feb 18;17(2):e1009378. doi: 10.1371/journal.pgen.1009378. eCollection 2021 Feb. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.